![]() 1,2 While remote cardiac monitoring has improved arrhythmia detection, patient compliance and timely access to heart activity remain a challenge with currently available competitive monitoring technologies. Atrial fibrillation (AFib) is the most frequent cardiac arrhythmia and a major risk factor for ischemic stroke. Heart arrhythmias are a major health concern and double the risk of death in an estimated 37.5 million people worldwide. In addition to the new Extended Wear Holter option, RhythMedix offers multiple modalities including mobile cardiac telemetry. The RhythmStar platform fits seamlessly into clinical practice and its interoperability support easily integrates with electronic medical record (EMR) systems. Unlike these systems, RhythmStar instantly transfers data wirelessly to enable faster ECG analysis with rapid report turnaround, so that care providers receive diagnostic reporting weeks faster than with mail back data retrieval methods. "We've monitored over 1 million patients and look forward to accelerating adoption of our innovative remote cardiac monitoring solution to reach even more patients."Īlternative monitoring systems require patients to send the wearable device back to the manufacturer for manual data retrieval, analysis and report generation. RhythMedix is committed to transforming and simplifying the diagnostic pathway to enable faster diagnosis, without missing a beat," stated Brian Pike, President, of RhythMedix. in 2021."We are especially pleased to launch expanded capabilities so close to National AFib Awareness Month. “We look forward to bringing this next-generation RhythmStar technology to physicians across the U.S. “We are excited to offer physicians and their patients our unique monitoring solution that improves patient compliance, helps accelerate diagnosis, and allows physicians to stay virtually connected to their patients with on-demand access to clinical data,” says Brian Pike, president, chief operations officer, and co-founder of RhythMedix. The device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event, and MCT) that connects patients and clinicians for improved patient care. “It also allows me to remain connected to my patients throughout their monitoring period, which may expedite a life-saving diagnosis.” “The novel wearable RhythmStar monitoring device offers increased patient compliance and allows for accurate assessment of cardiac rhythm in real time,” says Steven DaTorre, MD, a Clinical Cardiologist at Cooper University Health Care in New Jersey. While remote cardiac monitoring has improved arrhythmia detection, patient compliance and timely access to heart activity currently limit accurate and timely diagnosis. Heart arrhythmias are a major health concern that doubles the risk of death in an estimated 33.5 million people worldwide. ![]() RhythmStar is now available with HeartTime on-demand telemetry mode, an innovative platform that allows physicians to evaluate cardiac activity and expedite care via a telemedicine appointment, limiting the need for an in-person office visit. The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix’s team of US-based certified technicians, who alert physicians if an arrhythmia of concern is detected. The connected RhythmStar System provides the first and only wearable multi-modality cardiac monitoring (Holter, Extended Wear Holter, Event and MCT) device. The novel cardiac telemetry monitor is worn for extended remote monitoring without the need for an additional phone or communication device. ![]() RhythMedix, a Mount Laurel, N.J.-based remote cardiac monitoring company, has released its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |